Nfocus Neuromedical Acquires StarFire Medical

Nfocus Neuromedical Inc. said late Thursday it acquired StarFire Medical Inc., a maker of therapeutic implantable devices for minimally invasive treatment of neurovascular disease. Palo Alto, Calif.-based Nfocus did not disclose financial details of the deal for Plymouth-based StarFire. The assets acquired include products such as detachable and non-detachable silicone balloons, both of which have been cleared for marketing by the FDA and through CE marking in Europe. The acquisition also included other neurovascular devices and intellectual property. The remaining StarFire IP is focused on advanced intracranial aneurysm treatment devices that are in development. SOURCE: American City Business Journals